Yohimbine
Spécifications
146-48-5Numéro CAS
205-672-0Numéro CE
methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylateNom IUPAC
C21H26N2O3Formule chimique
354.4 g/molMasse molaire
Yohimbine; 146-48-5; Yohimbin; Quebrachine; Corynine; Quebrachin; APHRODINE; Yohimbic acid methyl ester; (+)-Yohimbine; Yohimbinum; DTXSID9040130; 17alpha-hydroxyyohimban-16alpha-carboxylic acid methyl ester; 2Y49VWD90Q; Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)-; methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate; (16alpha,17alpha)-17-hydroxyyohimban-16-carboxylic acid methyl ester; DTXCID7020130; CHEBI:10093; methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate; methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo(11.8.0.0^(2,10).0^(4,9).0^(15,20))henicosa-2(10),4,6,8-tetraene-19-carboxylate; Tartrate, Corynanthine; RefChem:56477; 205-672-0; Aphrosol; Johimbin; 17-Hydroxyyohimban-16-carboxylic acid methyl ester; MFCD00005093; methyl 17alpha-hydroxyyohimban-16alpha-carboxylate; CHEMBL15245; Actibine; YOHIMBINE CHLORIDE; 17alpha-hydroxy-yohimban-16alpha-carboxylic acid methyl ester; CHEMBL537669; Yohimbine (DCF); CAS-146-48-5; methyl hydroxy[?]carboxylate; EINECS 205-672-0; 17?-Hydroxy-yohimban-16?-carboxylic Acid Methyl Ester; BRN 0097276; trans-Quinolizidine yohimbine; UNII-2Y49VWD90Q; CCRIS 9415; SR-01000075297; Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv.; NSC19509; YOHIMBINE [MI]; Prestwick0_000584; Prestwick1_000584; Prestwick2_000584; Prestwick3_000584; Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester; YOHIMBINE [VANDF]; YOHIMBINUM [HPUS]; cid_6169; cid_8969; YOHIMBE HYDROCHLORIDE; YOHIMBINE [WHO-DD]; Lopac0_001210; SCHEMBL33954; BSPBio_000428; BSPBio_001236; GTPL102; KBioGR_000576; KBioSS_000576; 4-25-00-01237 (Beilstein Handbook Reference); MLS000728591; SPBio_002647; BPBio1_000472; orb1224339; orb1685173; Yohimbol-16alpha-carboxylic acid, methyl ester (6CI); SCHEMBL29385789; BCBcMAP01_000032; KBio2_000576; KBio2_003144; KBio2_005712; KBio3_001031; KBio3_001032; TCS2185; Bio1_000455; Bio1_000944; Bio1_001433; Bio2_000458; Bio2_000938; HMS1362N17; HMS1792N17; HMS1990N17; HMS2089G19; HMS2234C18; Tox21_110019; BDBM50013515; BDBM50203564; EBC-26708; AKOS015902024; Tox21_110019_1; Yohimban-16-.alpha.-carboxylic acid, 17-.alpha.-hydroxy-, methyl ester; Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester (8CI); CCG-205284; CS-5173; DB01392; FY01219; GS-5751; SDCCGSBI-0051177.P002; IDI1_002213; MRF-0000020; SMP1_000320; NCGC00013260-01; NCGC00025018-05; NCGC00025018-06; NCGC00025018-07; NCGC00025018-10; NCGC00025018-11; NCGC00025018-16; NCGC00025018-17; NCGC00025018-22; NCGC00025018-24; NCGC00025018-29; HY-12715; SMR000470778; 17a-hydroxy-16a-methoxycarbonyl-yohimbane; NS00003970; C09256; D08685; H10057; EN300-19731915; Q412226; SR-01000075297-5; BRD-K35586044-001-02-6; BRD-K35586044-003-03-0; BRD-K35586044-003-11-3; BRD-K35586044-003-14-7; BRD-K35586044-003-15-4; Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16|A,17|A)-; 17.ALPHA.-HYDROXY-20-.ALPHA.-YOHIMBAN-16-.BETA.-CARBOXYLIC ACID, METHYL ESTER; Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)- (9CI); (1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2'',3'':3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester hydrochloride; 103834-06-6; methyl (1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate hydrochloride; methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7-tetraene-19-carboxylateSynonymes
